ReCOV

· Jiangsu Rec-Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ReCOV, covering 2023-04-25 to 2024-02-29. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy, Safety and Immunogenicity Study of the Recombinant Two-component COVID-19 Vaccine (CHO Cell)(Recov) [Phase 3]

See pricing